Hage Kris, Koole Jeffrey, Boyd Anders, Matser Amy, Davidovich Udi, Bakker Margreet, van der Hoek Lia, Koopsen Jelle, Rebers Sjoerd, Schinkel Janke, Prins Maria
Department of Infectious Diseases, Public Health Service of Amsterdam.
Department of Infectious Diseases, Amsterdam UMC, University of Amsterdam.
Eur J Gastroenterol Hepatol. 2025 Oct 1;37(10):1173-1179. doi: 10.1097/MEG.0000000000003008. Epub 2025 Jun 23.
To assess the hepatitis C virus (HCV) prevalence, incidence, and associated determinants among men who have sex with men (MSM) without HIV in Amsterdam, the Netherlands.
We used data from the Amsterdam Cohort Studies (2012-2021) to calculate the prevalence of past/current HCV infection at the first study visit and incidence rate of primary HCV infection during follow-up. We identified determinants associated with incident HCV infection using univariable Bayesian exponential survival models. Phylogenetic analysis was conducted to compare HCV sequences of MSM without HIV to those from MSM with HIV and those using HIV pre-exposure prophylaxis.
A total of 926 MSM were included. At first visit, 2/926 (0.2%) had a past/current HCV infection. Among 891 participants contributing to 6083.30 person-years of follow-up, three incident HCV infections were observed (incidence rate = 0.05/100 person-years). These infections were observed between 2014 and 2018, and all participants had never used HIV pre-exposure prophylaxis. Incident infections were associated with receptive condomless anal sex, having 1-10 sexual partners vs. none, recent injecting drug use (IDU), ever IDU, and fisting, albeit there was substantial uncertainty for all determinants (i.e. 95% credible intervals included one). Phylogenetic analysis revealed that one HCV-RNA sequence was closely related to HCV sequences from MSM with HIV.
While HCV infection is uncommon among MSM without HIV, the risk of infection seems to increase among those with specific behaviors. HCV screening for MSM without HIV should be focused on those reporting these behaviors.
评估荷兰阿姆斯特丹未感染艾滋病毒的男男性行为者(MSM)中丙型肝炎病毒(HCV)的流行率、发病率及相关决定因素。
我们使用阿姆斯特丹队列研究(2012 - 2021年)的数据来计算首次研究访视时既往/当前HCV感染的流行率以及随访期间原发性HCV感染的发病率。我们使用单变量贝叶斯指数生存模型确定与新发HCV感染相关的决定因素。进行系统发育分析以比较未感染艾滋病毒的男男性行为者与感染艾滋病毒的男男性行为者以及使用艾滋病毒暴露前预防药物者的HCV序列。
共纳入926名男男性行为者。首次访视时,926人中有2人(0.2%)有既往/当前HCV感染。在891名参与者中,随访6083.30人年,观察到3例新发HCV感染(发病率 = 0.05/100人年)。这些感染发生在2014年至2018年期间,所有参与者从未使用过艾滋病毒暴露前预防药物。新发感染与无保护的接受性肛交、有1 - 10个性伴侣而非无、近期注射吸毒(IDU)、曾经注射吸毒以及拳交有关,尽管所有决定因素都存在很大不确定性(即95%可信区间包含1)。系统发育分析显示,一个HCV - RNA序列与感染艾滋病毒的男男性行为者的HCV序列密切相关。
虽然在未感染艾滋病毒的男男性行为者中HCV感染并不常见,但在有特定行为的人群中感染风险似乎增加。对未感染艾滋病毒的男男性行为者进行HCV筛查应集中在报告这些行为的人群。